Dal 1946 a fianco di professionisti e studenti Scopri cosa dicono di noi

Libri di Alan F. Schatzberg

Schatzberg's Manual of Clinical Psychopharmacology

Alan F. Schatzberg, Charles DeBattista

editore: American Psychiatric Association Publishing

pagine: 836

Schatzberg's Manual of Clinical Psychopharmacology is a meticulously researched, yet down-to-earth guide for practitioners prescribing psychotropic medications to individuals with psychiatric disorders or symptoms mandating treatment. The ninth edition offers up-to-date information on current drugs, interactions, side effects, and dosing guidelines, and retains the strengths and features that have made it a standard text for trainees and practicing clinicians. The authors also include a new chapter on important developments in laboratory-guided pharmacotherapy, including pharmacogenomic testing, neurocognitive testing, quantitative EEG, and neuroimaging. Although the book's primary purpose is to provide the reader-practitioner with basic and practical information regarding the many classes of psychiatric medications, the authors stress that understanding how to select and prescribe psychotropic medications does not obviate the basic need to comprehensively evaluate and understand psychiatric patients. Accordingly, the book draws on the authors' clinical experience, as well as on the scientific literature, resulting in an accessible, yet rigorous text. Features that have helped cement this book's reputation include: Coverage is not limited to long-standing and newly approved medications, but also includes agents that are likely to receive approval from the FDA in the near future, ensuring that the reader stays up-to-date. References are provided for key statements, and each chapter is then followed by a list of selected relevant articles and books for readers who want to go beyond the material presented, making for a leaner, more reader-friendly guide. Dozens of summary tables with key information on classes of psychotropics function as quick-reference guides, promoting learning and serving as convenient resources for overloaded clinicians. The appendix offers two kinds of suggested readings. The first, for clinicians, is invaluable to trainees, while the second, for patients and families, helps point clinicians to books aimed at a lay audience to supplement information provided to patients. Staying abreast of both new medications and promising treatment protocols is essential in this rapidly evolving field. Schatzberg's Manual of Clinical Psychopharmacology delivers authoritative information in a friendly, collegial style, ensuring that both students and practicing clinicians are equipped to provide a superior standard of care.
110,00 104,50

Manuale di psicofarmacologia clinica

Alan F. Schatzberg, Charles Debattista

editore: Giunti Organizzazioni Speciali

pagine: 663

Il testo rappresenta una guida aggiornata e facilmente consultabile della psicofarmacologia clinica. Alla luce del crescente numero di agenti farmacologici disponibili, caratterizzati da indicazioni sempre più estese, nella presente edizione si è dato spazio anche a nuovi farmaci che sono stati approvati, o sono in corso di approvazione, da parte della Food and Drug Administration (FDA) statunitense. In uno stile informale e accessibile si illustrano agenti farmacologici specifici, la loro efficacia, i dosaggi, gli effetti, e si forniscono tabelle riassuntive con le informazioni fondamentali sulle classi di agenti psicotropi, che serviranno da guida per una consultazione rapida. Per la gran parte, gli argomenti del volume sono "evidence based" - secondo il più accreditato metodo scientifico - ma ad essi si affiancano considerazioni dei due autori, frutto della loro pluriennale esperienza nell'ambito psichiatrico e psicofarmacologico.
90,00 85,50

Essentials of clinical psychopharmacology

Alan F. Schatzberg, Charles B. Nemeroff

editore: American Psychiatric Publishing

pagine: 880

Essentials of Psychopharmacology provides a synopsis and update of the most clinically relevant material included within its parent publication, The American Psychiatric Publishing Textbook of Psychopharmacology, a classic that has been hailed as indispensable to psychiatry residents and clinicians alike. This new third edition of the Essentials incorporates the latest research and treatment advances and presents key information in an accessible and easy-to-use manner. The chapter authors are among the foremost national authorities in their areas of expertise, and the content has been thoroughly referenced and meticulously edited for maximum utility. Among the features of this third edition are the following: * Commonsense organization that takes the reader through the various classes of psychotropic medications (with chapters focused on individual drugs in each class) to treatment using those drugs (with chapters addressing drug selection and therapeutic approaches to the treatment of patients with major psychiatric disorders).* Complete information on each drug's clinical pharmacology, pharmacokinetics, approved indications, dosages, side effects and toxicology, and drug-drug interactions.* Comprehensive coverage of the current psychotropic pharmacopoeia, including new chapters on the recently introduced antipsychotics asenapine, iloperidone, and lurasidone and updated chapters reflecting further accumulation of experience with other medications.* Extensive and thoroughly updated information on the use of psychotropic medications during pregnancy and lactation. Clinicians seeking a reliable reference and guide to the core knowledge base and practice of clinical psychopharmacology can do no better than this new edition of Essentials of Psychopharmacology.
155,00 147,25

The American Psychiatric Publishing Textbook of Psychopharmacology

Alan F. Schatzberg, Charles B. Nemeroff

editore: American Psychiatric Publishing

pagine: 1632

Its last edition hailed as "an essential volume for psychiatry residents as well as clinicians" (Journal of Psychiatric Practice), The American Psychiatric Publishing Textbook of Psychopharmacology is now updated to keep you abreast of the latest research and trends in the field. Covering both basic science and clinical practice, this new edition draws on the talents of 53 new contributors -- with the total increased from 139 to 158 -- to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy. Introductory chapters provide a theoretical grounding in clinical applications, with coverage ranging from neurotransmitters to clinical trial design. The "Classes of Psychiatric Treatment" section is a virtual pharmacopoeia, with chapters devoted to specific agents. It presents information by class of drug, and for each agent provides data on indications, side effects, interactions, and more -- including drugs likely to become available in the near future. Chapters in the "Clinical Psychobiology and Psychiatric Syndromes" section review the neurological underpinnings of specific disorders, providing a context for understanding psychopharmacological approaches to treatment. Coverage of those treatments encompasses state-of-the-art approaches to psychiatric disorders; specific patient populations, such as children and pregnant women; difficult-to-manage conditions like insomnia; and specific guidance on drug selection and prescription. Among the features of the fourth edition are the following * A new chapter on genomics and genetics covers basic methodologies and concepts to help you interpret the avalanche of data appearing in the human neuroscience literature.* Expanded chapters address newly approved agents, including the antidepressant desvenlafaxine, the antipsychotic paliperidone, and the anticonvulsant pregabalin.* A new chapter on the neurobiology of childhood disorders considers data relating to pervasive developmental disorders, psychoses, learning disorders, disruptive behavior disorder/ADHD, bipolar disorder, major depressive disorder, obsessive-compulsive disorder/Tourette's syndrome, PTSD, and pediatric anxiety disorders.* A new chapter on treatment of chronic pain syndromes discusses major classes of medications as they relate to pain management and covers prevalent disorders -- such as fibromyalgia and osteoarthritis -- in which this is a priority and for which evidence-based therapy is available.* A new, comprehensive review of ethical considerations in psychopharmacological treatment and research addresses such concerns as high-risk pharmacotherapy, long-acting medications, and off-label prescribing. Solidly established as an authoritative and comprehensive source, the new edition of this new edition of The American Psychiatric Publishing Textbook of Psychopharmacology is even more indispensable for clinicians and researchers alike.
280,00 266,00

The American Psychiatric Publishing Textbook of Mood Disorders

Alan F. Schatzberg, Dan J. Stein
e altri

editore: American Psychiatric Press Inc.

pagine: 792

Psychiatrists and other mental health care and medical professionals can now turn to a truly authoritative, up-to-date reference for current information about mood disorders. The American Psychiatric Publishing Textbook of Mood DisordersAincluding a wealth of illustrations, tables and referencesApresents the state of the art in diagnosis, psychobiology, pharmacotherapy, and psychotherapy across the vast spectrum of mood disorders: Symptomatology and Epidemiology: -Historical aspects and social underpinnings of mood disorders. -Classification and rating scales. -Global burden (the high costs of depression and bipolar disorder). Pathogenesis: -Neurochemistry and psychoneuroendocrinology. -Cognitive processing models (experimental cognitive research). -Evolutionary explanations (the normal role of low mood in disengaging individuals from goals they cannot reach). Methods of Investigation: -Anatomical pathology (strengths and limitations of human postmortem studies). -Molecular and cellular neurobiology of severe mood disorders (abnormalities in the regulation of signaling). -Genetics of bipolar and unipolar disorders. Types of Mood Disorder: -Psychotic depression (distinct from nonpsychotic depression in presenting features, biology, familial transmission, course, and response to treatment). -Seasonal affective disorder (use of light therapy in SADS and also in other depression). -Secondary depression with medical illness (calling for large-scale studies to gauge treatment efficacy). -Major depression seen in primary care (as prevalent as hypertension). -Substance abuse (a long-standing source of controversy). -Sleep disorders (risk factors for the new onset of depression). Treatments: -Pharmacotherapy (including tricyclics and tetracyclics, MAOIs, SSRIs and newer antidepressants, lithium and other mood stabilizers, antipsychotics, hormonal interventions, and augmentation strategies). -Brain stimulation techniques (such as ECT, transcranial magnetic stimulation, and vagus nerve and deep brain stimulation). -Psychotherapies (cognitive-behavioral, interpersonal, and psychoanalytic/psychodynamic). Pertinent Factors: -Personality (the need for further study of the degree and the etiologic nature of relationships between specific traits or disorders and major depression). -Culture (suggesting a model of cultural consultation using multilingual, multicultural clinicians and culture brokers to supplement routine care). -Gender (women being about twice as likely as men to have mood disorders) -Age (pediatric and geriatric depression and suicidality). Offering a fascinating synthesis of the multifaceted field of mood disorders, the richly informative American Psychiatric Publishing Textbook of Mood Disorders will prove invaluable for psychiatric and medical practitioners, educators, students, and residents interested in the latest breakthroughs in the diagnosis, treatment, and management of mood disorders.
130,00 123,50

Inserire il codice per il download.

Inserire il codice per attivare il servizio.